Towards Precision Medicine for Cerebrovascular Diseases

Dear Colleagues, 

Cerebrovascular diseases have seen an enormous advance of new treatment options, including endovascular management of large vessel occlusions for stroke, aneurysm treatment options, radiosurgery for arteriovenous malformations, and management of cavernous malformation. With a plethora of new and advancing treatment modalities, the importance of precision medicine for cerebrovascular disease is becoming increasingly more relevant. The purpose of this Special Issue ‘Toward Precision Medicine for Cerebrovascular Diseases’ is to invite studies that address an individualized approach to the prevention and management of cerebrovascular diseases. This Special Issue will look closely at the latest endovascular management options for stroke and aneurysms and how different treatment tools should be custom tailored to individual patients using the latest technology. Beyond endovascular and surgical treatment options, the availability of novel platelet inhibitors and oral anticoagulants makes the application of precision medicine concepts relevant for individualized treatment of patients suffering from strokes, atherosclerosis, and venous thrombosis. Finally, the prevention of cerebrovascular disease has undergone enormous progress, and understanding a patient’s individual risk factors will also be an important focus of this Special Issue.

Dr. Phil Taussky
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.